Learn More
Description
Specifications
Specifications
| Antigen | MAP3K8/Tpl2/COT |
| Applications | Western Blot, ELISA, Immunohistochemistry, Immunoprecipitation, Immunohistochemistry (Paraffin) |
| Classification | Polyclonal |
| Conjugate | Unconjugated |
| Dilution | Western Blot > 1:500, ELISA < 1:10000, Immunohistochemistry 1:50-1:150, Immunoprecipitation 1:200, Immunohistochemistry-Paraffin 1:50-1:150 |
| Formulation | Tris/Glycine buffer, pH 7.4; cryoprotective agents; HEPES; stabilizing protein (BSA 0.5%), and glycerol (30%). with 0.02% sodium azide |
| Gene Alias | Cancer Osaka thyroid oncogene, c-COT, cot (cancer Osaka thyroid) oncogene, COTMEKK8, EC 2.7.11.25, ESTF, ESTFLJ10486, Ewing sarcoma transformant, mitogen-activated protein kinase kinase kinase 8, Proto-oncogene c-Cot, proto-oncogene serine/threoine protein kinase, Serine/threonine-protein kinase cot, Tpl-2, TPL2, Tumor progression locus 2, tumor progression locus-2 |
| Gene Symbols | MAP3K8 |
| Host Species | Rabbit |
| Immunogen | Synthetic peptides corresponding to unique epitope on MAP3K8. The peptide sequence was selected from C-terminal-region, amimo acids 365-467. This peptide was covalently modified post-synthetically to achieve desired antigenicity. |
| Show More |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
